SCHEMBL20898255

SCHEMBL20898255

CC1(C)C[C@H]2CN(c3ccc(N4CCOCC4)cc3)[C@@H]1CNC2=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 2/20 0.38
PDE3A Q14432 2/20 0.38
MAPT P10636 10/20 0.36
ALDH1A1 P00352 8/20 0.36
KDM4E B2RXH2 5/20 0.36
MEN1 O00255 6/20 0.35
KMT2A Q03164 6/20 0.35
KIF11 P52732 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 1/20 0.35
ERBB2 P04626 1/20 0.35
RET P07949 1/20 0.35
PDGFRB P09619 1/20 0.35
USP2 O75604 1/20 0.35
TP53 P04637 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22567430 0.86 KDM4E (0.36) ALDH1A1KDM4E
SCHEMBL20898337 0.86 KDM4E (0.36) ALDH1A1KDM4E
SCHEMBL22567318 0.86 KDM4E (0.36) ALDH1A1KDM4E
SCHEMBL22567417 0.86 KDM4E (0.36) ALDH1A1KDM4E
SCHEMBL22555819 0.86 KDM4E (0.36) ALDH1A1KDM4E
SCHEMBL20907313 0.86 IDH1 (0.31)
SCHEMBL22567453 0.86 IDH1 (0.31)
SCHEMBL20898281 0.86 IDH1 (0.31)
SCHEMBL22555807 0.83 ADAMTS5 (0.34) ALDH1A1SMN1; SMN2HTTTDP1
SCHEMBL22567582 0.82 GAA (0.38) ALDH1A1KDM4EHPGDHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12060360-B2 Lysyl oxidase inhibitors THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2024-08-13 US disclosed
US-20220289757-A1 LYSYL OXIDASE INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2022-09-15 US disclosed
US-11325915-B2 Lysyl oxidase inhibitors THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2022-05-10 US disclosed
US-11325915-B2 Lysyl oxidase inhibitors THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2022-05-10 US disclosed
US-20200331922-A1 LYSYL OXIDASE INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2020-10-22 US disclosed
US-20200331922-A1 LYSYL OXIDASE INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2020-10-22 US disclosed
EP-3694857-A1 LYSYL OXIDASE INHIBITORS The Institute of Cancer Research: Royal Cancer Hospital (GB) 2020-08-19 EP disclosed
WO-2019073251-A1 LYSYL OXIDASE INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2019-04-18 WO disclosed
WO-2019073251-A1 LYSYL OXIDASE INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2019-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331922-A1 LYSYL OXIDASE INHIBITORS LOXL1, LOXL2, LOXL3 PDE3B 2851/4885PDE3A 3119/4885MAPT 3461/4885
US-12060360-B2 Lysyl oxidase inhibitors LOXL1, LOXL2, LOXL3 PDE3B 2851/4885PDE3A 3119/4885MAPT 3461/4885
US-20220289757-A1 LYSYL OXIDASE INHIBITORS LOXL1, LOXL2, LOXL3 PDE3B 2851/4885PDE3A 3119/4885MAPT 3461/4885
US-11325915-B2 Lysyl oxidase inhibitors LOXL1, LOXL2, LOXL3 PDE3B 2851/4885PDE3A 3119/4885MAPT 3461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.